A lot more goes into building, and those other prices aren't dropping.

Cushman & Wakefield shares three key indicators that a fast recovery is underway.

"Lenders and borrowers seem to be more inclined to provide a path to survival."

Borrowers' growing risk appetite is fueling increased demand for transitional financing, such as bridge loans.

Los Angeles, Chicago, and Houston are emerging life science markets.

US Sunbelt markets are the latest for the company, which announced a joint venture with Arch Street Capital

However it did raise its expectations for a 2022 growth rate to 3.2% from 2.8%.

At the same time it has just closed on four office transactions totaling $1.04 billion in value.